Soluble Arctic amyloid β protein inhibits hippocampal long-term potentiation in vivo

European Journal of Neuroscience

Volumn 19, Issue 10, 2004, Pages 2839-2846

  Klyubin, Igor ^a   Walsh, Dominic M ^b,c   Cullen, William K ^a   Fadeeva, Julia V ^b   Anwyl, Roger ^a   Selkoe, Dennis J ^b   Rowan, Michael J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; CA1 area; Peptide aggregation; Rat; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED; GLUTAMIC ACID; GLUTAMINE; GLYCINE; PEPTIDE; URETHAN;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CENTRIFUGATION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HIPPOCAMPUS; IN VIVO STUDY; INHIBITION KINETICS; INJECTION; LONG TERM POTENTIATION; MALE; MUTANT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLUBILITY; STIMULATION; SUPERNATANT; VELOCITY; WILD TYPE;

AMYLOID BETA-PROTEIN; ANIMALS; CONGO RED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRODES, IMPLANTED; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; GLYCINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MUTATION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 2942626182     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03389.x     Document Type: Article

References (58)

1. Chen, Q.S., Kagan, B.L., Hirakura, Y. & Xie, C.W. (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. J. Neurosci. Res., 60, 65-72.
2. Citron, M. (2002) Emerging Alzheimer's disease therapies: inhibition of β-secretase. Neurobiol. Aging, 23, 1017-1022.
3. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. & Selkoe, D.J. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature, 360, 672-674.
4. Clements, A., Allsop, D., Walsh, D.M. & Williams, C.H. (1996) Aggregation and metal-binding properties of mutant forms of the amyloid Aβ peptide of Alzheimer's disease. J. Neurochem., 66, 740-747.
5. Clements, A., Walsh, D.M., Williams, C.H. & Allsop, D. (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neurosci. Lett. 161, 17-20.
6. Cullen, W.K., Suh, Y.H., Anwyl, R. & Rowan, M.J. (1997) Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. Neuroreport, 8, 3213-3217.
7. Dahlgren, K.N., Manelli, A.M., Stine, W.B. Jr, Baker, L.K., Krafft, G.A. & LaDu, M.J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem., 277, 32046-32053.
8. De Jonghe, C., Zehr, C., Yager, D., Prada, C.M., Younkin, S., Hendriks. L., Van Broeckhoven, C. & Eckman, C.B. (1998) Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion. Neurobiol. Dis., 5, 281-286.
9. DeMattos, R.B., Bales, K.R., Cummins, D.J., Dodart, J.C., Paul, S.M. & Holtzman, D.M. (2001) Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 98, 8850-8855.
10. Demeester, N., Mertens, C., Caster, H., Goethals, M., Vandekerckhove, J., Rosseneu, M. & Labeur, C. (2001) Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid β peptides. Eur. J. Neurosci., 13, 2015-2024.
11. van Duinen, S.G., Castano, E.M., Prelli, F., Bots, G.T., Luyendijk, W. & Frangione, B. (1987) Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc. Natl. Acad. Sci. USA, 84, 5991-5994.
12. Fraser, P.E., Nguyen, J.T., Inouye, H., Surewicz, W.K., Selkoe, D.J., Podlisny, M.B. & Kirschner, D.A. (1992) Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry, 31, 10716-10723.
13. Ghersi-Egea, J.F., Gorevic, P.D., Ghiso, J., Frangione, B., Patlak, C.S. & Fenstermacher, J.D. (1996) Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem., 67, 880-883.
14. Goate, A., Chartier-Harlon, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., & Hardy, J. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349, 704-706.
15. Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A. & Klein, W.L. (2003) Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA, 100, 10417-10422.
16. Hardy, J. & Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci., 12, 383-388.
17. Harper, J.D. & Lansbury, P.T. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem., 66, 385-407.
18. Hartley, D.M., Walsh, D.M., Ye, C.P., Diehl, T., Vasquez, S., Vassilev, P.M., Teplow, D.B. & Selkoe, D.J. (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci., 19, 8876-8884.
19. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. & Malinow, R. (2003) APP processing and synaptic function. Neuron, 27, 925-937.
20. Kamino, K., Orr, H.T., Payami, H., Wijsman, E.M., Alonso, M.E., Pulst, S.M., Anderson, L., O'dahl, S., Nemens, E., White, J.A., Sadovnick, A.D., Ball, M.J., Kaye, J., Warren, A., Mcinnis, M., Antonarakis, S.E., Korenberg, J.R., Sharma, V., Kukull, W., Larson, E., Heston, L.L., Martin, G.M., Bird, T.D. & Schellenberg, G.D. (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am. J. Hum. Genet., 51, 998-1014.
21. Klunk, W.E., Pettegrew, J.W. & Abraham, D.J. (1989) Quantitative evaluation of congo red binding to amyloid-like proteins with a β-pleated sheet conformation. J. Histochem. Cytochem., 37, 1273-1281.
22. Kumar-Singh, S., Dewachter, I., Moechars, D., Lubke, U., De Jonghe, C., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P., Van Broeckhoven, C. & Van Leuven, F. (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol. Dis., 7, 9-22.
23. Laakso, M.P. (2002) Structural imaging in cognitive impairment and the dementias: an update. Curr. Opin. Neurol., 15, 415-421.
24. Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhang, C., Finch, C.E., Krafft, G.A. & Klein, W.L. (1998) Diffusible, nonfibrillar ligands derived from Aβ (1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA, 95, 6448-6453.
25. Lashuel, H.A., Hartley, D.M., Petre, B.M., Wall, J.S., Simon, M.N., Walz, T. & Lansbury, P.T. (2003) Mixtures of wild-type and a pathogenic (E22G) form of Aβ40 in vitro accumulate protofibrils, including amyloid pores. J. Mol. Biol., 332, 795-808.
26. Ling, Y., Morgan, K. & Kalsheker, N. (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int. J. Biochem. Cell. Biol., 35, 1505-1535.
27. Michaelis, M.L. (2003) Drugs targeting Alzheimer's disease: some things old and some things new. J. Pharmacol. Exp. Ther., 304, 897-904.
28. Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B. & Ghiso, J. (2000) Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem., 275, 27110-27116.
29. Monro, O.R., Mackic, J.B., Yamada, S., Segal, M.B., Ghiso, J., Maurer, C., Calero, M., Frangione, B. & Zlokovic, B.V. (2002) Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging, 23, 405-412.
30. Morelli, L., Llovera, R., Gonzalez, S.A., Affranchino, J.L., Prelli, F., Frangione, B., Ghiso, J. & Castano, E.M. (2003) Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J. Biol. Chem., 278, 23221-23226.
31. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. & Lannfelt, L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet., 1, 345-347.
32. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T. & Shirasawa, T. (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ 1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem. Biophys. Res. Commun., 294, 5-10.
33. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T. & Shirasawa, T. (2003) Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's Disease. J. Biol. Chem., 278, 46179-46187.
34. Natte, R., Maat-Schieman, M.L., Haan, J., Bornebroek, M., Roos, R.A. & van Duinen, S.G. (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol., 50, 765-772.
35. Nilsberth, C., Westlind-Danielsson, A., Eckman, C.B., Condron, M.M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D.B., Younkin, S.G., Naslund, J. & Lannfelt, L. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci., 4, 887-893.
36. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. & LaFerla, RM. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron, 39, 409-421.
37. Perez, A., Morelli, L., Cresto, J.C. & Castano, E.M. (2000) Degradation of soluble amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem. Res., 25, 247-255.
38. Qiu, W.Q., Walsh, D.M.YeZ., Vekrellis, K., Zhang, J., Podlisny, M.B., Rosner, M.R., Safavi, A., Hersh, L.B. & Selkoe, D.J. (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem., 273, 32730-32738.
39. Rowan, M.J., Klyubin, I., Cullen, W.K. & Anwyl, R. (2003) Synaptic plasticity in animal models of early Alzheimer's disease. Phil. Trans. R. Soc. Lond. B, 358, 821-828.
40. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498.
41. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins and therapies. Physiol. Rev., 81, 742-761.
42. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science, 298, 789-791.
43. Sennvik, K., Nilsberth, C., Stenh, C., Lannfelt, L. & Benedikz, E. (2002) The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells. Neurosci. Lett., 326, 51-55.
44. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest., 106, 1489-1499.
45. Sian, A.K., Frears, E.R., El-Agnaf, O.M., Patel, B.P., Manca, M.F., Siligardi, G., Hussain, R. & Austen, B.M. (2000) Oligomerization of β-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types. Biochem. J., 349, 299-308.
46. Stephan, A., Laroche, S. & Davis, S. (2001) Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci., 21, 5703-5714.
47. Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L. Jr, Eckman, C., Golde, T.E. & Younkin, S.G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (beta APP717) mutants. Science, 264, 1336-1340.
48. Tsubuki, S., Takaki, Y. & Saido, T.C. (2003) Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation. Lancet, 361, 1957-1958.
49. Turner, P.R., O'Connor, K., Tate, W.P. & Abraham, W.C. (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol., 70, 1-32.
50. Van Nostrand, W.E., Melchor, J.P., Cho, H.S., Greenberg, S.M. & Rebeck, G.W. (2001) Pathogenic effects of D23N Iowa mutant amyloid β-protein. J. Biol. Chem., 376, 32680-33266.
51. Verbeek, M.M., Eikelenboom, P. & de Waal, R.M. (1997) Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol., 56, 751-761.
52. Walsh, D.M., Hartley, D.M., Condron, M.M., Selkoe, D.J. & Teplow, D.B. (2001) In vitro studies of amyloid β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692 → Gly) Alzheimer's disease. Biochem. J., 355, 869-877.
53. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. & Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535-539.
54. Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem., 272, 22364-22372.
55. Wang, H.W., Pasternak, J.F., Kuo, H., Ristic, H., Lambert, M.P., Chromy, B., Viola, K.L., Klein, W.L., Stine, W.B., Krafft, G.A. & Trommer, B.L. (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res., 924, 133-140.
56. Watson, D.J., Selkoe, D.J. & Teplow, D.B. (1999) Effects of the amyloid precursor protein Glu693 → Gln 'Dutch' mutation on the production and stability of amyloid β-protein. Biochem. J., 340, 703-709.
57. Wattendorf, A.R., Bots, G.T., Went, L.N. & Endtz, L.J. (1982) Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J. Neurol. Sci., 55, 121-135.
58. Xu, L., Anwyl, R. & Rowan, M.J. (1998) Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus. Nature, 394, 891-894.